[HTML][HTML] Targeting signaling pathways in epithelial ovarian cancer
Ovarian carcinoma (OC) is the most lethal gynecological malignancy. Response to platinum-
based chemotherapy is poor in some patients and, thus, current research is focusing on new …
based chemotherapy is poor in some patients and, thus, current research is focusing on new …
Targeting Signaling Pathways in Epithelial Ovarian Cancer
E Smolle, V Taucher, M Pichler, E Petru… - International …, 2013 - search.proquest.com
Ovarian carcinoma (OC) is the most lethal gynecological malignancy. Response to platinum-
based chemotherapy is poor in some patients and, thus, current research is focusing on new …
based chemotherapy is poor in some patients and, thus, current research is focusing on new …
Targeting signaling pathways in epithelial ovarian cancer
E Smolle, V Taucher, M Pichler… - International …, 2013 - pubmed.ncbi.nlm.nih.gov
Ovarian carcinoma (OC) is the most lethal gynecological malignancy. Response to platinum-
based chemotherapy is poor in some patients and, thus, current research is focusing on new …
based chemotherapy is poor in some patients and, thus, current research is focusing on new …
[HTML][HTML] Targeting Signaling Pathways in Epithelial Ovarian Cancer
E Smolle, V Taucher, M Pichler, E Petru… - … Journal of Molecular …, 2013 - ncbi.nlm.nih.gov
Ovarian carcinoma (OC) is the most lethal gynecological malignancy. Response to platinum-
based chemotherapy is poor in some patients and, thus, current research is focusing on new …
based chemotherapy is poor in some patients and, thus, current research is focusing on new …
Targeting Signaling Pathways in Epithelial Ovarian Cancer.
E Smolle, V Taucher, M Pichler… - International …, 2013 - search.ebscohost.com
Ovarian carcinoma (OC) is the most lethal gynecological malignancy. Response to platinum-
based chemotherapy is poor in some patients and, thus, current research is focusing on new …
based chemotherapy is poor in some patients and, thus, current research is focusing on new …
Targeting signaling pathways in epithelial ovarian cancer.
E Smolle, V Taucher, M Pichler, E Petru… - … Journal of Molecular …, 2013 - europepmc.org
Purpose We want to give an overview on the molecular genetic changes of the
histopathological types of OC and their role as putative therapeutic targets. In Depth Review …
histopathological types of OC and their role as putative therapeutic targets. In Depth Review …
Targeting signaling pathways in epithelial ovarian cancer
E Smolle, V Taucher, M Pichler… - International …, 2013 - mdanderson.elsevierpure.com
Ovarian carcinoma (OC) is the most lethal gynecological malignancy. Response to platinum-
based chemotherapy is poor in some patients and, thus, current research is focusing on new …
based chemotherapy is poor in some patients and, thus, current research is focusing on new …
[PDF][PDF] Targeting Signaling Pathways in Epithelial Ovarian Cancer
E Smolle, V Taucher, M Pichler, E Petru, S Lax… - Int. J. Mol …, 2013 - researchgate.net
Ovarian carcinoma (OC) is the most lethal gynecological malignancy. Response to platinum-
based chemotherapy is poor in some patients and, thus, current research is focusing on new …
based chemotherapy is poor in some patients and, thus, current research is focusing on new …
Targeting signaling pathways in epithelial ovarian cancer
E Smolle, V Taucher, M Pichler, E Petru, S Lax… - 2013 - opus.bibliothek.uni-augsburg.de
Ovarian carcinoma (OC) is the most lethal gynecological malignancy. Response to platinum-
based chemotherapy is poor in some patients and, thus, current research is focusing on new …
based chemotherapy is poor in some patients and, thus, current research is focusing on new …
[PDF][PDF] Targeting Signaling Pathways in Epithelial Ovarian Cancer
E Smolle, V Taucher, M Pichler, E Petru, S Lax… - Int. J. Mol …, 2013 - cyberleninka.org
Ovarian carcinoma (OC) is the most lethal gynecological malignancy. Response to platinum-
based chemotherapy is poor in some patients and, thus, current research is focusing on new …
based chemotherapy is poor in some patients and, thus, current research is focusing on new …